AEPCX
Price
$61.92
Change
+$0.71 (+1.16%)
Updated
Aug 21 closing price
Net Assets
137.41B
BGEFX
Price
$15.45
Change
+$0.19 (+1.25%)
Updated
Aug 21 closing price
Net Assets
3.06B
Interact to see
Advertisement

AEPCX vs BGEFX

AEPCX vs BGEFX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. BGEFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a StrongBuy and BGEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. BGEFX (3.06B). AEPCX pays higher dividends than BGEFX: AEPCX (2.13) vs BGEFX (0.17). AEPCX was incepted earlier than BGEFX: AEPCX (25 years) vs BGEFX (12 years). AEPCX (1.58) is less costly to investors than BGEFX (0.47). AEPCX is a more actively managed with annual turnover of: 50.00 vs. BGEFX (21.00). AEPCX has a lower initial minimum investment than BGEFX: AEPCX (250) vs BGEFX (200000000). BGEFX (7.49) and AEPCX (7.17) have marching annual gain over last year. AEPCX return over 5 years is better than : -3.27 vs. BGEFX (-24.92).
AEPCXBGEFXAEPCX / BGEFX
Total Expense Ratio1.580.47336%
Annual Report Gross Expense Ratio1.580.47336%
Fund Existence25 years12 years-
Gain YTD7.18410.44169%
Front LoadN/AN/A-
Min. Initial Investment2502000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets137B3.06B4,477%
Annual Yield % from dividends2.130.171,257%
Returns for 1 year7.177.4996%
Returns for 3 years26.1033.0479%
Returns for 5 years-3.27-24.9213%
Returns for 10 years40.0462.5464%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSEDX21.640.15
+0.70%
Columbia Intrinsic Value Institutional 2
ADCYX24.870.15
+0.61%
American Century Disciplined Growth Y
MFECX112.680.63
+0.56%
MFS Growth C
BAUAX31.760.15
+0.47%
Brown Advisory Small-Cap Fdmtl Val Adv
APFDX21.160.09
+0.43%
Artisan Global Discovery Investor